Prevalence and patterns of HIV transmitted drug resistance in Guatemala

Avila-Ríos, Santiago; Mejía-Villatoro, Carlos R; García-Morales, Claudia; Soto-Nava, Maribel; Escobar, Ingrid; Mendizabal, Ricardo; Girón, Amalia; García, Leticia; Reyes-Terán, Gustavo.
Rev. panam. salud pública ; 30(6): 641-648, Dec. 2011.
Artículo en Inglés | LILACS | ID: lil-612963

Documentos relacionados

  1. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
  2. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
  3. Resistencia transmitida de VIH-1 en pacientes sin exposición a tratamiento antirretroviral: Guatemala
  4. Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
  5. Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.
  6. The prevalence of HIV resistance mutations and their influence on the shedding of HIV-1 into peritoneal dialysis effluent.
  7. Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries.
  8. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary.
  9. Elasticity-Associated Functionality and Inhibition of the HIV Protease.
  10. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.